Latest news with #IndraprasthaMedicalCorporation
Mint
13 hours ago
- Automotive
- Mint
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 30 June 2025
Breakout stocks buy or sell: The Indian stock market extended its winning streak for the fourth consecutive session on Friday, June 27, buoyed by largely positive global trends. The Sensex rose by 303 points, or 0.36%, to settle at 84,058.90, while the Nifty 50 gained 89 points, or 0.35%, closing at 25,637.80. Broad-based buying was observed across the market, with the BSE Midcap index up by 0.38% and the Smallcap index increasing by 0.54%. In the last four sessions, the Sensex has surged by 2,162 points, marking a nearly 3% rise, with the Nifty 50 mirroring this upward trend. Sumeet Bagadia, Executive Director at Choice Broking, believes that Indian stock market sentiment has improved as the Nifty 50 index closed above its previous days close. Speaking on the outlook of Indian stock market, Bagadia said, ' The key benchmark index is heading towards the immediate target of 25,700, while on the lower side, it has made a strong base in 25,300 to 35,250 levels. So, one should maintain stock-specific approach and look at those stocks that are looking strong on the technical chart. Looking at breakout stocks can be a good option." Sumeet Bagadia recommends five breakout stocks to buy today: NDR Auto Components, Indraprastha Medical Corporation, LT Foods, Redington, and SML Isuzu. 1] NDR Auto Components: Buy at ₹ 1078.55, target ₹ 1150, stop loss ₹ 1035; 2] Indraprastha Medical Corporation: Buy at ₹ 449.35, target ₹ 477, stop loss ₹ 432; 3] LT Foods: Buy at ₹ 483.25, target ₹ 515, stop loss ₹ 465; 4] Redington: Buy at ₹ 322.05, target ₹ 345, stop loss ₹ 310; 5] SML Isuzu: Buy at ₹ 2034.1, target ₹ 2160, stop loss ₹ 1965. Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
Mint
4 days ago
- Business
- Mint
Anand Rathi sees 40% rally in multibagger healthcare stock despite 600% rise in five years
Stock Market Today: Anand Rathi sees a 40% rally in a Multibagger healthcare stock. This is despite a 600% rise in five years in the Indraprastha Medical Corporation Ltd. share price. Check details Anand Rathi remains positive on the Multibagger healthcare stock Indraprastha Medical Corporation, maintaining it as a top pick, and expects about 40% upside to the target price of ₹ 590. The Indraprastha Medical Corporation share price has risen more than 69% in a year. while it has grown almost 4-fold in the last two years. The Indraprastha Medical Corporation share price is up almost 613% in the last 5 years and has given Multibagger returns to the investors. The primary re-rating trigger, as per Anand Rathi Research, is the Delhi government's stake sale expectation in the company As per Anand Rathi, referring to their interaction with the management, they say that it was revealed that the promoters are negotiating to purchase all or a portion of the Delhi government's 26% stake, which they currently hold. Although the timeline is uncertain, as per Anand Rathi Research, they think that if the deal proceeds, it will create more room for expansion in both emerging and existing regions, including the NCR. Indraprastha is expanding its bed capacity from the present 802 beds. The expansions at its current location in Sarita Vihar (Delhi) are in accordance with the industry's expansion of bed capacity, with 350 beds anticipated to be added by mid-CY28. The projected cost of this is ₹ 580 crore. About 40% of the project's cost is anticipated to be spent in FY26, with the remaining amount falling in FY27 and FY28. Because the corporation is spending about Rs1.8 billion to create two underground floors for parking (about 1,300 automobiles and 350+ two-wheelers), the cost per bed is greater for this site. The goal is to increase the number of beds to approximately 1,800 at one location, which would likely be the largest number of beds at one location. Anand Rathi research says that, further, with the new government coming in, Delhi should augur well for the company as it can expedite the Delhi government's stake sale to the promoters (can be an option value). They have broadly maintained their estimates for FY26 and FY27. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Business Standard
17-05-2025
- Business
- Business Standard
Indraprastha Medical Corporation standalone net profit rises 31.57% in the March 2025 quarter
Sales rise 6.04% to Rs 333.75 crore Net profit of Indraprastha Medical Corporation rose 31.57% to Rs 41.01 crore in the quarter ended March 2025 as against Rs 31.17 crore during the previous quarter ended March 2024. Sales rose 6.04% to Rs 333.75 crore in the quarter ended March 2025 as against Rs 314.73 crore during the previous quarter ended March 2024. For the full year,net profit rose 29.87% to Rs 160.99 crore in the year ended March 2025 as against Rs 123.96 crore during the previous year ended March 2024. Sales rose 8.97% to Rs 1356.36 crore in the year ended March 2025 as against Rs 1244.70 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 333.75314.73 6 1356.361244.70 9 OPM % 18.3715.39 - 18.0115.53 - PBDT 66.1851.77 28 260.65206.19 26 PBT 55.2741.56 33 216.32166.11 30 NP 41.0131.17 32 160.99123.96 30
